Looking for a specific product?

Make a search for products & suppliers, articles & news.

Bionor Pharma ASA - Successful completion of subsequent offering

Reference is made to the prospectus dated 7 October 2013 and the stock exchange announcement dated 8 October 2013 concerning the subsequent offering (the "Subsequent Offering") of up to 7,500,000 shares (the "Offer Shares") in Bionor Pharma ASA (the "Company") at a subscription price of NOK 2.75 per share. The Company reports that the Subsequent Offering was oversubscribed. 

The subscription period in the Subsequent Offering ended on 22 October 2013 at 16.30 (CET). As a result of the Subsequent Offering, the Company will issue 7,500,000 Offer Shares at NOK 2.75 per share raising gross proceeds of approximately NOK 20.6 million.

All subscribers being allotted Offer Shares will receive a letter confirming the number of Offer Shares allotted to the subscriber and the corresponding amount to be paid. This letter is expected to be distributed on or about today's date.

To read more, please visit Bionor Pharma's website.

Associated companies:


Related news

Latest news

World's fastest ROV? - Project ROST

Traditionally, all cleaning has been carried out from a workboat,

New regional manager takes the helm in key oil and gas markets for DNV GL

Elaborating on the differences in the energy markets which now lie under his new responsibilities in DNV GL,

DNV GL launches certification framework and recommended practice for Carbon Capture and Storage (CCS)

The recommended practice DNVGL-RP-F104 Design and operation of carbon dioxide pipelines, 

DNV GL launches new JDP to test biodegradable lubricants

The test programme will investigate such aspects as hydrodynamic oil film formation,

ROV contracts in Brazil

The new contracts and contract extensions give 1 630 days of ROV services...

Steinsvik Secures a Contract for its First Concrete Barge

Steinsvik’s well-known steel barge design is now complemented by a new and innovative concrete barge design.

Searching for the best biological solutions

AKVA group’s biologists play a key role to ensure that the company’s technology not only meets fish welfare requirements, but also provides the best possible conditions for the fish.

Elisabeth Maråk Støle appointed managing director of Forskningsselskapet SørVest AS

Elisabeth Maråk Støle will take up her position on 1 April 2018 at the latest.

TIME SCALE

We are building chambers for tomatoes to grow in space. The aim is to give food to astronauts going to Mars.